Advertisement
AD

Main navigation

Advertisement
AD

IOHK's Charles Hoskinson Teases Cardano 2022 Roadmap Release

Advertisement
Sat, 13/11/2021 - 15:22
IOHK's Charles Hoskinson Teases Cardano 2022 Roadmap Release
Cover image via www.youtube.com
Read U.TODAY on
Google News
Advertisement

Charles Hoskinson, co-founder and CEO of Input Output Global (IOG), the team behind Cardano's blockchain solutions, announces what to expect from its next roadmap.

"The technology is unbelievable"

Mr. Hoskinson has taken to Twitter to share his expectations and impressions of Cardano's next roadmap, which is designed to cover the platform's prospects for 2022.

According to him, Cardano (ADA) accomplished formidable growth in terms of ecosystem building: its "living" ecosystem is getting stronger.

Advertisement

All projects interested in building on Cardano's smart contracts should expect many great innovations for their mechanisms as Cardano's technology is "unbelievable," Mr. Hoskinson adds.

This statement was met with patented criticism by Ethereum (ETH) maximalists. In particular, they recalled the narrative about Cardano's UTXO model opportunity to process only one transaction per block.

Crucial year for Cardano (ADA)

The year 2022 will be a special year for Cardano: it is the first year that will be approached by the platform with fully activated smart contracts functionality.

As covered by U.Today previously, Cardano (ADA) became a programmable blockchain in August, after the mainnet implementation of Alonzo hardfork.

Related

This release was the most significant one for Cardano (ADA) in 2021. Also, on March 31, 2021, Cardano (ADA) governance migrated to its staking pools.

Related

In 2020, the protocol activated hotly anticipated staking for its core native asset, ADA.

A
A
A

Related articles

Advertisement
TopCryptoNewsinYourMailbox
TopCryptoNewsinYourMailbox
Advertisement
Advertisement

Recommended articles

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD